Hongjiang Xu
- Molecular Biology
- Organic Chemistry top 10%
- Microbiology top 5%
- Oncology
- Endocrinology, Diabetes and Metabolism
- Topics
- Peptidase Inhibition and Analysis (6 papers)Diabetes Treatment and Management (6 papers)Cancer therapeutics and mechanisms (5 papers)
In The Last Decade
Hongjiang Xu
40 papers receiving 765 citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 373
- Organic Chemistry 192
- Microbiology 124
- Oncology 106
- Endocrinology, Diabetes and Metabolism 89
Countries citing papers authored by Hongjiang Xu
This map shows the geographic impact of Hongjiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjiang Xu more than expected).
Fields of papers citing papers by Hongjiang Xu
This network shows the impact of papers produced by Hongjiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjiang Xu. The network helps show where Hongjiang Xu may publish in the future.
Co-authorship network of co-authors of Hongjiang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongjiang Xu. A scholar is included among the top collaborators of Hongjiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjiang Xu. Hongjiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 27 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 6 | |
| 10 | 27 | |
| 11 | 24 | |
| 12 | 18 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 14 | |
| 16 | 12 | |
| 17 | 22 | |
| 18 | 54 | |
| 19 | 12 | |
| 20 | 43 |
About Hongjiang Xu
Hongjiang Xu is a scholar working on Molecular Medicine, Endocrinology, Diabetes and Metabolism and Oncology, having authored 41 papers that have together received 773 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Diabetes Treatment and Management (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Microbiology (124 citations), Molecular Medicine (43 citations) and Organic Chemistry (192 citations). Hongjiang Xu has collaborated with scholars based in China, Sudan and Hong Kong. Frequent co-authors include Jun Feng, Jie Ma, Jun Xu, Yanan Li, Hongmei Gu, Xiquan Zhang, Ling‐Dong Kong, Yan‐Zi Yang, Jiabi Zhu and Jiu Wang. Their work appears in journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.